127 related articles for article (PubMed ID: 38087680)
1. Lymphocyte transformation tests predict delayed-type allergy to piperacillin/tazobactam in patients with cystic fibrosis.
Roehmel JF; Rohrbach A; Staab D; Mall MA; Ogese M; Doerfler F; Naisbitt D
J Cyst Fibros; 2024 May; 23(3):573-578. PubMed ID: 38087680
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic allergy in children with cystic fibrosis: A retrospective case-control study.
Süleyman A; Tamay Z; Güler N
Pediatr Pulmonol; 2022 Nov; 57(11):2622-2628. PubMed ID: 35833362
[TBL] [Abstract][Full Text] [Related]
3. Piperacillin-Tazobactam Hypersensitivity: A Large, Multicenter Analysis.
Casimir-Brown RS; Kennard L; Kayode OS; Siew LQC; Makris M; Tsilochristou O; Chytiroglou E; Nakonechna A; Rutkowski K; Mirakian R; Wagner A
J Allergy Clin Immunol Pract; 2021 May; 9(5):2001-2009. PubMed ID: 33444815
[TBL] [Abstract][Full Text] [Related]
4. Delayed hypersensitivity to acylureidopenicillins: a case report.
Gaeta F; Alonzi C; Valluzzi RL; Viola M; Romano A
Allergy; 2008 Jun; 63(6):787-9. PubMed ID: 18445197
[No Abstract] [Full Text] [Related]
5. Use of the lymphocyte transformation test in the diagnosis of DRESS syndrome induced by ceftriaxone and piperacillin-tazobactam: two case reports.
Jurado-Palomo J; Cabañas R; Prior N; Bobolea ID; Fiandor-Román AM; López-Serrano MC; Quirce S; Bellón T
J Investig Allergol Clin Immunol; 2010; 20(5):433-6. PubMed ID: 20945612
[TBL] [Abstract][Full Text] [Related]
6. Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
LeCleir LK; Pettit RS
Pediatr Pulmonol; 2017 Aug; 52(8):1000-1005. PubMed ID: 28440913
[TBL] [Abstract][Full Text] [Related]
7. Is high-dose β-lactam therapy associated with excessive drug toxicity in critically ill patients?
McDonald C; Cotta MO; Little PJ; McWhinney B; Ungerer JP; Lipman J; Roberts JA
Minerva Anestesiol; 2016 Sep; 82(9):957-65. PubMed ID: 27054905
[TBL] [Abstract][Full Text] [Related]
8. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
Hess U; Böhme C; Rey K; Senn HJ
Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
[TBL] [Abstract][Full Text] [Related]
9. Life-threatening piperacillin-induced immune haemolysis in a patient with cystic fibrosis.
Marik PE; Parekh P
BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23291922
[TBL] [Abstract][Full Text] [Related]
10. Delayed-type hypersensitivity reaction to piperacillin/tazobactam in a patient with an infected total knee replacement.
Song EK; Seon JK; Jeong MS
J Bone Joint Surg Br; 2010 Nov; 92(11):1596-9. PubMed ID: 21037360
[TBL] [Abstract][Full Text] [Related]
11. Allergy to beta-lactam antibiotics in children.
Ponvert C; Le Clainche L; de Blic J; Le Bourgeois M; Scheinmann P; Paupe J
Pediatrics; 1999 Oct; 104(4):e45. PubMed ID: 10506270
[TBL] [Abstract][Full Text] [Related]
12. Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial.
Kaye KS; Bhowmick T; Metallidis S; Bleasdale SC; Sagan OS; Stus V; Vazquez J; Zaitsev V; Bidair M; Chorvat E; Dragoescu PO; Fedosiuk E; Horcajada JP; Murta C; Sarychev Y; Stoev V; Morgan E; Fusaro K; Griffith D; Lomovskaya O; Alexander EL; Loutit J; Dudley MN; Giamarellos-Bourboulis EJ
JAMA; 2018 Feb; 319(8):788-799. PubMed ID: 29486041
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with cystic fibrosis-related acute pulmonary exacerbations.
Butterfield JM; Lodise TP; Beegle S; Rosen J; Farkas J; Pai MP
J Antimicrob Chemother; 2014 Jan; 69(1):176-9. PubMed ID: 23869050
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests.
Arikoglu T; Aslan G; Batmaz SB; Eskandari G; Helvaci I; Kuyucu S
Int J Clin Pharm; 2015 Aug; 37(4):583-91. PubMed ID: 25822038
[TBL] [Abstract][Full Text] [Related]
15. Flucloxacillin Hypersensitivity: Patient Outcomes in a Multicenter Retrospective Study.
Kennard L; Rutkowski K; Siew LQC; Nakonechna A; Sargur R; Egner W; Shrimpton A; Mirakian R; Wagner A
J Allergy Clin Immunol Pract; 2019; 7(7):2212-2217.e1. PubMed ID: 30922988
[TBL] [Abstract][Full Text] [Related]
16. The controversy of drug hypersensitivity in patients with cystic fibrosis and review of the literature.
Tugcu GD; Emiralioglu N; Yalcin E; Sahiner UM; Dogru D; Sekerel BE; Ozcelik U; Kiper N; Soyer O
Pediatr Allergy Immunol; 2022 Feb; 33(2):e13719. PubMed ID: 34907613
[TBL] [Abstract][Full Text] [Related]
17. Rapid-Onset Thrombocytopenia Following Piperacillin-Tazobactam Reexposure.
Nguyen VD; Tourigny JF; Roy R; Brouillette D
Pharmacotherapy; 2015 Dec; 35(12):e326-30. PubMed ID: 26684560
[TBL] [Abstract][Full Text] [Related]
18. Fever and Reversible Laboratory Abnormalities Associated with Prolonged Use of Piperacillin-Tazobactam in Children.
Patel A; Mao KR; McNeil JC; Kaplan SL; Vallejo JG
Pediatr Infect Dis J; 2015 Aug; 34(8):849-50. PubMed ID: 25961892
[TBL] [Abstract][Full Text] [Related]
19. Nonimmediate β-lactam reactions in patients with cystic fibrosis.
Whitaker P; Naisbitt D; Peckham D
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):369-75. PubMed ID: 22729028
[TBL] [Abstract][Full Text] [Related]
20. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
Tellado J; Woods GL; Gesser R; McCarroll K; Teppler H
Surg Infect (Larchmt); 2002; 3(4):303-14. PubMed ID: 12697078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
